UNIVERSITY OF TENNESSEE HEALTH SCI CTR
Mitoprotective therapies for kidney injury
Mitoprotective therapies for kidney injury is a funding opportunity from UNIVERSITY OF TENNESSEE HEALTH SCI CTR, up to 3010432, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
ABSTRACT Acute kidney injury (AKI) is a common disease that is associated with adverse short and long-term sequelae. AKI usually occurs in hospitalized patients and in the settings of other clinical conditions, such as sepsis, rhabdomyolysis, and cardiovascular and oncological diseases, where the underlying disease…